000 00999 a2200289 4500
005 20250518020225.0
264 0 _c20191118
008 201911s 0 0 eng d
022 _a2374-2445
024 7 _a10.1001/jamaoncol.2018.6504
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPashayan, Nora
245 0 0 _aOverestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.
_h[electronic resource]
260 _bJAMA oncology
_c03 2019
300 _a428-429 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aBreast Neoplasms
650 0 4 _aCost-Benefit Analysis
650 0 4 _aEarly Detection of Cancer
650 0 4 _aHumans
650 0 4 _aMammography
650 0 4 _aMass Screening
650 0 4 _aUnited Kingdom
700 1 _aPharoah, Paul D P
773 0 _tJAMA oncology
_gvol. 5
_gno. 3
_gp. 428-429
856 4 0 _uhttps://doi.org/10.1001/jamaoncol.2018.6504
_zAvailable from publisher's website
999 _c29264055
_d29264055